- Home
- BCRX vs GAB Comparison
BCRX vs GAB Comparison
Compare BCRX & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- GAB
- Stock Information
- Founded
- BCRX 1986
- GAB 1986
- Country
- BCRX United States
- GAB United States
- Employees
- BCRX N/A
- GAB N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- GAB Investment Managers
- Sector
- BCRX Health Care
- GAB Finance
- Exchange
- BCRX Nasdaq
- GAB Nasdaq
- Market Cap
- BCRX 1.8B
- GAB 1.9B
- IPO Year
- BCRX 1994
- GAB N/A
- Fundamental
- Price
- BCRX $7.28
- GAB $6.02
- Analyst Decision
- BCRX Strong Buy
- GAB
- Analyst Count
- BCRX 10
- GAB 0
- Target Price
- BCRX $16.70
- GAB N/A
- AVG Volume (30 Days)
- BCRX 3.1M
- GAB 667.8K
- Earning Date
- BCRX 11-03-2025
- GAB 01-01-0001
- Dividend Yield
- BCRX N/A
- GAB 10.91%
- EPS Growth
- BCRX N/A
- GAB N/A
- EPS
- BCRX N/A
- GAB N/A
- Revenue
- BCRX $557,506,000.00
- GAB N/A
- Revenue This Year
- BCRX $41.40
- GAB N/A
- Revenue Next Year
- BCRX $5.33
- GAB N/A
- P/E Ratio
- BCRX N/A
- GAB N/A
- Revenue Growth
- BCRX 45.85
- GAB N/A
- 52 Week Low
- BCRX $6.02
- GAB $4.56
- 52 Week High
- BCRX $11.31
- GAB $5.88
- Technical
- Relative Strength Index (RSI)
- BCRX 38.42
- GAB 41.42
- Support Level
- BCRX $7.24
- GAB $6.07
- Resistance Level
- BCRX $7.47
- GAB $6.18
- Average True Range (ATR)
- BCRX 0.20
- GAB 0.07
- MACD
- BCRX -0.02
- GAB -0.02
- Stochastic Oscillator
- BCRX 34.85
- GAB 3.85
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About GAB Gabelli Equity Trust Inc. (The)
Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.